The Rhumbline Advisers Raises its position in Biogen Inc. (BIIB) as a favorable investment target.

Posted under Uncategorized on December 11th, 2016 by

The fund owned 357,364 shares of the biotechnology company’s stock after buying an additional 8,533 shares during the period. Rhumbline Advisers’ …

Leave a Comment